Welcome to our dedicated page for Terrascent news (Ticker: TSNDF), a resource for investors and traders seeking the latest updates and insights on Terrascent stock.
TerrAscend Corp. (TSNDF) generates frequent news as a TSX-listed cannabis company with operations across the North American cannabis sector. Company updates often focus on its multi-state footprint in the United States, retail operations in Canada, and its combination of cultivation, processing, manufacturing and dispensary activities serving medical and legal adult-use cannabis markets.
News releases commonly cover quarterly financial results, where TerrAscend reports revenue, margins, cash flow and non-GAAP measures such as EBITDA from continuing operations, Adjusted EBITDA and Free Cash Flow. These earnings updates also describe performance in key markets such as New Jersey, Maryland, Pennsylvania, Ohio and California, and explain how strategic decisions, including the exit from the Michigan market, affect its financial profile.
Investors following TerrAscend’s news can also expect announcements about financing and capital structure, including details of senior secured syndicated term loans, refinancing of existing debt and the availability of additional uncommitted term loan facilities for mergers and acquisitions. The company has additionally reported on a normal course issuer bid authorizing share repurchases over a specified period and has disclosed the number of shares repurchased and related pricing under previous programs.
Another recurring theme in TerrAscend’s news is strategic transactions and partnerships. Examples include the option agreement and related financing for Union Chill Cannabis Company LLC in New Jersey, as well as an exclusive licensing agreement with Tyson 2.0 to manufacture and distribute branded cannabis products in Maryland and Pennsylvania. The company’s releases also highlight acquisitions of dispensaries in markets such as Ohio and expansions of cultivation and manufacturing capacity in states like Maryland and New Jersey.
For readers tracking TSNDF news, this page offers a consolidated view of TerrAscend’s earnings announcements, financing developments, asset sales and acquisitions, licensing partnerships and operational updates across its North American cannabis operations.
TerrAscend (OTCQX: TSNDF) will host a conference call to discuss fourth quarter and full year results for the period ended December 31, 2025 on Thursday, March 12, 2026 at 5:00 p.m. Eastern Time. Financial results will be released the same day after market close. Call and webcast details are provided for investor access.
Webcast: https://app.webinar.net/EPJ9wXNjKl1 | Dial-in: 1-888-510-2154 | Replay: 1-289-819-1450 or 1-888-660-6345 (available until March 26, 2026, entry code 77201#).
TerrAscend (OTCQX: TSNDF) closed its acquisition of Union Chill, a Hunterdon County dispensary, expanding its New Jersey retail footprint to four dispensaries and supporting a consolidated network of 20 dispensaries across five U.S. states and Canada upon option exercise and conditions. The deal totals $13 million (a $9 million convertible-note option at 6.5% interest plus $4 million cash on exercise). Union Chill currently generates over $11 million in annualized revenue and the company says the asset is expected to be immediately accretive to EBITDA and cashflow.
The transaction conforms to New Jersey regulatory rules for diverse ownership and is positioned to integrate TerrAscend’s premium brands to drive sales and margins.
TerrAscend (OTCQX: TSNDF) announced an exclusive licensing agreement with Tyson 2.0, the cannabis brand founded by Mike Tyson, to launch Tyson 2.0 products in Maryland and Pennsylvania.
In Maryland TerrAscend will manufacture and distribute premium flower, vapes, and edibles. In Pennsylvania the lineup will include flower, vapes, concentrates, and troches sold through Apothecarium retail stores and the company's wholesale network. Products are expected to reach Apothecarium locations and select dispensaries in the new year. The announcement emphasizes brand partnership and state-by-state product rollouts.
TerrAscend (OTCQX: TSNDF) reported Q3 2025 results: Net revenue $65.1M, Gross margin 52.1% (up 110 bps YoY), Adjusted EBITDA $17.0M (26.1% margin) and GAAP net loss $9.9M from continuing operations. Cash and cash equivalents were $36.6M. The company generated $7.1M net cash from continuing operations and $4.9M free cash flow, marking the 13th and 9th consecutive quarters of positive cash flow respectively. During Q3 TerrAscend closed a $79M senior secured term loan refinancing and secured an additional uncommitted $35M facility for M&A. Management plans to divest Michigan assets by year-end to repay debt.
TerrAscend (OTCQX: TSNDF) rescheduled its third quarter 2025 earnings conference call to Thursday, November 6, 2025 at 8:30 a.m. ET. The company will report financial results for the quarter ended September 30, 2025 earlier that day in advance of the call. Investors can join via webcast or dial-in; a replay will be available until midnight ET on Thursday, November 20, 2025.
Conference details: Webcast: https://app.webinar.net/6dvVkb2k4bz. Dial-in: 1-888-510-2154. Replay numbers: 1-289-819-1450 or 1-888-660-6345 with entry code 73897#.
TerrAscend (OTCQX: TSNDF) will host a conference call to discuss third quarter results for the period ended September 30, 2025 on Thursday, November 6, 2025 at 5:00 p.m. Eastern Time. The company will release its Q3 2025 financial results the same day after market close.
Investors can join the webcast at https://app.webinar.net/6dvVkb2k4bz or dial 1-888-510-2154. A replay is available until midnight Eastern Time on November 20, 2025 at 1-289-819-1450 or 1-888-660-6345 (Replay code: 73897#).
TerrAscend (OTCQX: TSNDF), a prominent North American cannabis company, has announced the renewal and replenishment of its share repurchase program for up to $10 million of common shares over a 12-month period.
Under the previous NCIB program, TerrAscend purchased 1,279,400 shares at an average price of $0.47 per share, totaling approximately $616,000. The new program authorizes the repurchase of up to 10 million shares, representing 4.73% of the public float, with daily purchases limited to 60,255 shares. The program will run from August 22, 2025, to August 21, 2026.
The company maintains flexibility in the program's execution, with no obligation to purchase shares if management identifies better uses for cash reserves. TerrAscend plans to fund the buyback through existing cash reserves without incurring debt.
TerrAscend (OTCQX: TSNDF) reported Q2 2025 financial results with net revenue of $65.0 million and a gross profit margin of 51.1% from continuing operations. The company announced its strategic exit from the Michigan market and completed a $79 million non-dilutive refinancing with an additional $35 million facility available for M&A.
Key highlights include the company's 12th consecutive quarter of positive cash flow from continuing operations and 8th consecutive quarter of positive free cash flow. TerrAscend maintained market leadership in New Jersey, achieved a $75 million revenue run rate in Maryland, and saw growth in Pennsylvania. The company reported an Adjusted EBITDA of $16.0 million with a 24.6% margin.
TerrAscend (OTCQX: TSNDF), a leading North American cannabis company, has scheduled its second quarter 2025 earnings conference call for Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. The company will release its Q2 2025 financial results after market close on the same day.
Investors can access the conference call via webcast or dial-in, with replay available until August 21, 2025. The webcast will be accessible through the company's dedicated webinar platform.
TerrAscend (OTCQX: TSNDF), a leading North American cannabis company, has secured a $79 million non-dilutive debt financing through a senior secured syndicated term loan. The transaction, led by FocusGrowth Asset Management, includes using $68 million to retire existing debt, with the remainder allocated for future growth initiatives.
The loan carries a 12.75% interest rate and matures in August 2028, with no prepayment penalties. Additionally, an uncommitted term loan facility of up to $35 million will be available for future M&A opportunities. The financing includes insider participation from Executive Chairman Jason Wild, who invested approximately $1.6 million as part of the loan syndicate.
FAQ
What is the current stock price of Terrascent (TSNDF)?
What is the market cap of Terrascent (TSNDF)?
